Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
Scroll Up
Scroll Down

Reaction Optimisation 2
Bookmark and Share

Syrris Ltd

This application note describes the optimisation of 2 out of 4 substitution reactions given to Syrris by a pharmaceutical company. The pharma company in question had attempted some reaction optimisation by traditional techniques but always had starting material remaining, even after a week long reaction. The starting materials (of commercial sensitivity) were given to Syrris with the objective of using the Africa synthesis & analysis system to optimise to 100% conversion.

100% conversion was achieved for all 4 reactions.

Further Information

Related Content

Syrris Invites Chemists to Join Free Flow Chemistry Workshop in the US
Syrris is hosting a free flow chemistry workshop in Cambridge, Massachusetts, USA, on the 9th of May 2013.
Monday, April 22, 2013
Syrris Acclaimed for Latin American Presence
Extensive progress acknowledged following the opening of the Brazilian subsidiary.
Saturday, October 09, 2010
Syrris Announces Outstanding Success Following Expansion of Worldwide Operations
The Company has experienced strong 2010 start by opening its Brazilian subsidiary and new product launches.
Friday, July 16, 2010
Syrris to Host Technical Seminars in India for R&D Chemists
Applications-focused seminars to explore calorimetry, sonocrystallization and flow chemistry solutions.
Monday, May 10, 2010
Syrris Establishes Indian Subsidiary
Company expands its sales network and service support for all customers in India.
Monday, July 27, 2009
Syrris to Further Extend its Global Outreach with new Distributors Across Europe, Asia and the Middle East
Syrris has appointed three sales and customer support personnel and six distributors to support its new modular flow chemistry and synthesis systems.
Thursday, December 06, 2007
Academics Get to Test Flow Chemistry System for Free
Syrris has announced the winners of its competition to win the use of its new FRX300 flow chemistry system.
Monday, October 22, 2007
Win a Flow Chemistry System
Syrris is providing scientists with the opportunity to win one month’s free use of one of its FRX systems, the FRX300, including delivery, training and system support.
Monday, June 18, 2007
Syrris Announce new West Coast Office
To meet the growing Customer demand, Syrris expands its US sales and customer service team with the opening of an office in La Jolla, CA, to provide support for its modular flow chemistry and synthesis products.
Thursday, March 15, 2007
Buoyant Order Book Spurs Recruitment Drive at Syrris
Syrris to double sales force for its FRX and atlas as these systems demonstrate the success of the modular approach.
Tuesday, January 30, 2007
Syrris Appointed as North American Distributor of Lara and Coflux Product Lines
Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R&D Summit in Philadelphia.
Monday, October 03, 2005
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!